Serum nitric oxide metabolites in subjects with metabolic syndrome

Yoon, 2002, Smoking status-dependent association of the 27-bp repeat polymorphism in intron 4 of endothelial nitric oxide synthase gene with plasma nitric oxide concentrations, Clinica. Chimica. Acta, 324, 113, 10.1016/S0009-8981(02)00235-8 Dudzinski, 2006, The regulation and pharmacology of endothelial nitric oxide synthase, Annu. Rev. Pharmacol. Toxicol., 46, 235, 10.1146/annurev.pharmtox.44.101802.121844 Ding, 2000, Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression, Am. J. Physiol. Endocrinol. Metab., 279, E11, 10.1152/ajpendo.2000.279.1.E11 Jansson, 2007, Endothelial dysfunction in insulin resistance and type 2 diabetes, J. Intern. Med., 262, 173, 10.1111/j.1365-2796.2007.01830.x Kim, 2006, Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms, Circulation, 113, 1888, 10.1161/CIRCULATIONAHA.105.563213 Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285:2486–97. Ueyama, 2008, Association of serum NOx level with clustering of metabolic syndrome components in middle-aged and elderly general populations in Japan, Environ. Health Prev. Med., 13, 36, 10.1007/s12199-007-0001-1 Maejima, 2001, Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects. Relationship to microvascular complications, J. Diabetes Complications, 15, 135, 10.1016/S1056-8727(01)00144-1 Perreault, 2001, Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle, Nat. Med., 7, 1138, 10.1038/nm1001-1138 Colasanti, 2000, The dual personality of NO, Trends Pharmacol. Sci., 21, 249, 10.1016/S0165-6147(00)01499-1 Dallaire, 2004, Obesity-linked insulin resistance: is nitric oxide the missing link?, Can. J. Diabetes, 28, 59 Moshage, 1995, Nitrite and nitrate determinations in plasma: a critical evaluation, Clin. Chem., 41, 892, 10.1093/clinchem/41.6.892 Miranda, 2001, A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite, Nitric. Oxide., 5, 62, 10.1006/niox.2000.0319 Romitelli, 2007, Comparison of nitrite/nitrate concentration in human plasma and serum samples measured by the enzymatic batch Griess assay, ion-pairing HPLC and ion-trap GC–MS: the importance of a correct removal of proteins in the Griess assay, J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 851, 257, 10.1016/j.jchromb.2007.02.003 Kagota, 2006, Disturbances in nitric oxide/cyclic guanosine monophosphate system in SHR/NDmcr-cp rats, a model of metabolic syndrome, Life. Sci., 78, 1187, 10.1016/j.lfs.2005.06.029 Ellis, 1998, Nitrite and nitrate analyses: a clinical biochemistry perspective, Clin. Biochem., 31, 195, 10.1016/S0009-9120(98)00015-0 Azizi, 2002, Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1), Soz. Praventivmed., 47, 408, 10.1007/s000380200008 Ghasemi, 2007, Protein precipitation methods evaluated for determination of serum nitric oxide end products by the Griess assay, JMSR, 2, 43 1997, Report of the expert committee on the diagnosis and classification of diabetes mellitus, Diabetes Care, 20, 1183, 10.2337/diacare.20.7.1183 Behr-Roussel, 2000, Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-l-lysine or with l-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits, Circulation, 102, 1033, 10.1161/01.CIR.102.9.1033 Zhou, 2000, Lipotoxic heart disease in obese rats: implications for human obesity, Proc. Natl. Acad. Sci. U. S. A., 97, 1784, 10.1073/pnas.97.4.1784 Schwartz, 1997, Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats, J. Clin. Invest., 100, 439, 10.1172/JCI119551 Shankar, 2000, Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance, Diabetes, 49, 684, 10.2337/diabetes.49.5.684 Scherrer, 2000, Defective nitric oxide synthesis: a link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity, Eur. J. Endocrinol., 142, 315, 10.1530/eje.0.1420315 Cui, 2007, Metabolic syndrome and urinary cGMP excretion in general population, Atherosclerosis, 190, 423, 10.1016/j.atherosclerosis.2006.02.032 Chien, 2005, Increased plasma concentration of nitric oxide in type 2 diabetes but not in nondiabetic individuals with insulin resistance, Diabetes Metab., 31, 63, 10.1016/S1262-3636(07)70168-4 Honing, 1998, Nitric oxide availability in diabetes mellitus, Diabetes Metab. Rev., 14, 241, 10.1002/(SICI)1099-0895(1998090)14:3<241::AID-DMR216>3.0.CO;2-R Shimabukuro, 1997, Role of nitric oxide in obesity-induced beta cell disease, J. Clin. Invest., 100, 290, 10.1172/JCI119534 Himeno, 2003, A practical procedure for achieving a steady state of NOx concentration in plasma: with special reference to the NOx content of Japanese daily food, Tohoku. J. Exp. Med., 199, 95, 10.1620/tjem.199.95 Node, 1997, Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension, Hypertension, 30, 405, 10.1161/01.HYP.30.3.405 Bryan, 2007, Methods to detect nitric oxide and its metabolites in biological samples, Free Radic. Biol. Med., 43, 645, 10.1016/j.freeradbiomed.2007.04.026 Grattagliano, 2008, Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis, J. Nutr. Biochem., 19, 491, 10.1016/j.jnutbio.2007.06.011 Maeda, 2001, Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans, Life Sci., 69, 1005, 10.1016/S0024-3205(01)01192-4